ArticleBMC health services research2026
Economic burden of COVID-19 on hospitalized patients: a cross-sectional study from Semnan, Iran.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOne of the responsibilities of health systems is to protect citizens from the financial burdens caused by disease. This study aimed to estimate the economic burden of the coronavirus disease 2019 (COVID-19) on hospitalized patients and identifying its determinants.
methodsThe current cross-sectional study was conducted during the sixth peak of COVID-19 in Iran (summer and fall 2021) with the participation of 400 hospitalized patients at Kowsar Hospital in Semnan from the patients' perspective. The data was collected using the patients' medical records and through interviewing with the patients. We used a researcher-made questionnaire, whose content validity was confirmed by scores of 0.91 and 0.93, respectively, for content validity ratio (CVR) and content validity index (CVI). Depending on the nature of the independent and dependent variables, student's t-test, analysis of variance (ANOVA), Chi-square, linear regression, and Tukey's post-hoc tests were used.
resultsThe economic estimations revealed that hospitalized COVID-19 patients and their families paid 2773.43 USD (116484080 IRR) monthly, of which 1833.43 USD (77004080 IRR) (66%) was related to direct medical costs, 357.97 USD (15035000 IRR) (13%) to direct non-medical costs, and 582.02 USD (24445000 IRR) (21%) to indirect costs. In addition to the factors relating to the severity of the disease and its side effects, a wide range of demographic and contextual factors, including age, gender, residence status, residence region (urban or rural), type of basic and supplementary insurance, location of care, presence of an underlying disease, and receiving medication for the underlying disease had an impact on the total cost.
conclusionsAccording to our results, COVID-19 hospitalization had a significant financial impact on hospitalized patients and their families, just like complicated procedures or chronic severe illnesses. We also identified significant geographic, economic, and employment-related health inequities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.